Stock listing

Cellectar Biosciences, Inc.

Selected listing: NV40 · FWB · EUR · DE

Cellectar Biosciences, Inc. (Frankfurt:NV40), Health Technology. Latest release Sep 29, 2026: Cellectar Biosciences to Present Compelling Efficacy Data…

NV40:FWBEURDEUpdated October 2, 2026
Cellectar Biosciences, Inc. logo
Ticker
Frankfurt:NV40
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Frankfurt
Currency
EUR

About Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.

Latest news from Cellectar Biosciences, Inc.

All Cellectar Biosciences, Inc. news →

Events

Replays

  • Cellectar Biosciences, Inc. (CLRB) Q2 2026 Earnings Call

    Thu, Aug 13, 2026 · 08:30 AM ET

    Watch
  • Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call

    Thu, May 14, 2026 · 08:30 AM ET

    Watch
  • Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call

    Wed, Mar 04, 2026 · 08:30 AM ET

    Watch

Research Cellectar Biosciences, Inc.

Alternate listings